LXR Signaling Controls Complement-Mediated NETosis: A New Therapeutic Target in Diabetic Kidney Disease: SA-PO0325

Journal article

Peer reviewed

Sarah Hamade, Sarah Almoussawi, Sahar Alkhansa, Rachel Njeim, Ghaith S. El Danaf, Batoul Dia, Hala M. KFoury, Fuad N. Ziyadeh and Assaad Antoine Eid

Journal of the American Society of Nephrology, Vol.36(10S), 10.1681/ASN.202575r299as

2025-10

Metrics

1 Record Views

Title: LXR Signaling Controls Complement-Mediated NETosis: A New Therapeutic Target in Diabetic Kidney Disease
Creators: Sarah Hamade - American University of Beirut
Sarah Almoussawi - American University of Beirut
Sahar Alkhansa - American University of Beirut
Rachel Njeim - University of Miami
Ghaith S. El Danaf - American University of Beirut
Batoul Dia - American University of Beirut
Hala M. KFoury - American University of Beirut Medical Center
Fuad N. Ziyadeh - American University of Beirut Medical Center
Assaad Antoine Eid - American University of Beirut
Publication Details: Journal of the American Society of Nephrology, Vol.36(10S), 10.1681/ASN.202575r299as
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Nephrology & Hypertension Div
Language: English
Resource Type: Journal article
Record Identifier: 991032861102202976